免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Upper Limb Robot-Assisted Therapy in Patients With Guillain-Barré Syndrome

NCT:NCT06620198 · ACTIVE_NOT_RECRUITING

NCT IDNCT06620198
狀態ACTIVE_NOT_RECRUITING
開始日期2024-10-01
完成時間2027-10-01
SponsorI.R.C.C.S. Fondazione Santa Lucia (OTHER)
First posted
Last updated

簡要摘要

Guillain-Barré Syndrome is an immune-mediated polyradiculoneuropathy, with around 100,000 new cases reported worldwide annually. The aim of this double-blind randomized controlled trial with a SHAM control group is to evaluate the effects of robot-assisted therapy, integrated with conventional therapy, on upper limb motor recovery in patients with GBS.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑